EUCTR2005-002407-17-DE进行中（未招募）不适用
Effects of rosiglitazone on renal hemodynamics and proteinuria of type 2 diabetic patients with renal insufficiency due to overt diabetic nephropathy
Technical University Dresden0 个研究点目标入组 38 人开始时间: 2005年12月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-type 2 diabetes mellitus
- •-age between 40 and 70 years
- •-well controlled HbA1c (< 7.5%)
- •-chronic renal failure (creatinin clearance between 70 and 30 mL/(min x 1.73 m²) according to the Cockroft equation)
- •-proteinuria > 300 mg / 24 hours
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-type 1 diabetes
- •-poorly controlled type 2 diabetes (HbA1c > 7.5%) or unstable blood glucose during the day (capillary blood glucose self monitoring)
- •-elevation of ALT, AST or GGT more than 2.5 fold the upper normal value
- •-CHF (more than grade 1 of NYHA)
- •-uncontrolled hypertension
- •-malignant tumorous disorder
- •-hyper- or hypothyroidism
- •-pregnant women
- •-nursing women
研究者
相似试验
已完成
不适用
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic NephropathyOvert Diabetic NephropathyType 2 DiabetesNCT00324675Technische Universität Dresden28
已完成
不适用
Effect of Rosiglitazone on Vascular Function in Patients with Advanced Chronic Kidney DiseaseAdvanced Chronic kidney diseaseVascular functionRenal and Urogenital - Kidney diseaseACTRN12605000690651Raine Medical Research foundation (pending)70
已完成
不适用
Effect of pioglitazone on renal function amelioration by measurement of cystatine C levels in the type 2 diabetic patientsDiabetic nephropathyJPRN-UMIN000000689Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine70
进行中（未招募）
不适用
Renal Hemodynamic Effects of ALiskiren (rasilez) in comparison to ramipril (Tritrace) in patients with overweigHt/obeSiTy and UntreateD hYpertension: The renal HEALTH-STUDY - The renal HEALTH-STUDYEUCTR2010-021987-13-NLniversity Medical Center Groningen16
已完成
3 期
Renal hemodynamic effects of aliskiren (rasilez) in comparison to ramipril (tritrace) in patients with overweight/obesity and hypertensiosystemische en glomerulaire hypertensieelevated blood pressure in the kidneyglomerular hypertensionNL-OMON34045niversitair Medisch Centrum Groningen16